Protagenic Therapeutics, Inc.\new Impairment of Intangible Assets (Excluding Goodwill)
Protagenic Therapeutics, Inc.\new (PTIX) reported Impairment of Intangible Assets (Excluding Goodwill) of $13.34 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new impairment of intangible assets (excluding goodwill) for the quarter ending 2026-06-30 was $13.34K.
- Protagenic Therapeutics, Inc.\new impairment of intangible assets (excluding goodwill) for the quarter ending 2011-09-30 was $1.42M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month |
|---|---|---|
| 2026-06-30 | $13.34K 10-Q · filed 2026-08-19 | |
| 2011-09-30 | $1.42M 10-Q · filed 2011-11-14 | $1.42M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |